Summary of ‘Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents’
✍ Scribed by Andrea Milne
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 47 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1557-6272
- DOI
- 10.1002/ebch.257
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
This is a summary of a Cochrane review, published in this issue of EBCH, first published as: Hetrick SE, Merry S, McKenzie J, Sindahl R, Protctor M. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD004851. DOI: 10.1002/14651858.CD004851.pub2.
Further information for this Cochrane review is available in this issue of EBCH in the accompanying EBCH Commentary and Characteristics and Key Findings Tables. Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. The Cochrane Collaboration
📜 SIMILAR VOLUMES
## Abstract This is a commentary on a Cochrane review, published in this issue of EBCH, first published as: Hetrick SE, Merry S, McKenzie J, Sindahl R, Protctor M. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. __Cochrane Database of Systematic
This retrospective chart review examines the impact of selective serotonin reuptake inhibitors on 20 patients with both depression and psychosis complicating dementia of the Alzheimer type (DAT) and other dementias. Fifteen of the 20 patients had moderate to marked improvement in depressive and psyc